The optims trial: the first prospective long term predictivity analysis trial of a treatment response marker to immunomodulatory drug in ms

MLA

Durelli, Luca, et al. The Optims Trial: The First Prospective Long Term Predictivity Analysis Trial of a Treatment Response Marker to Immunomodulatory Drug in Ms. Jan. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......970..ee54a704bf80e73d2f3d29e2d29df979&authtype=sso&custid=ns315887.

APA

Durelli, L., Barbero, P., Clerico, M., Ricci, A., Ferrero, B., Contessa, G., Versino, E., Giuliani, G., Montanari, E., And The Optims Study Group, & Italy. (2005). The optims trial: the first prospective long term predictivity analysis trial of a treatment response marker to immunomodulatory drug in ms.

Chicago

Durelli, Luca, P. Barbero, Marinella Clerico, A. Ricci, B. Ferrero, G. Contessa, Elisabetta Versino, et al. 2005. “The Optims Trial: The First Prospective Long Term Predictivity Analysis Trial of a Treatment Response Marker to Immunomodulatory Drug in Ms,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od.......970..ee54a704bf80e73d2f3d29e2d29df979&authtype=sso&custid=ns315887.